2022 年 39 巻 4 号 p. 506-509
Mechanical thrombectomy was began by the advent of Merciretriever in 2010. The effectiveness of mechanical thrombectomy was first reported in 2015 and the indication have been expanded recently. Physicians involved in stroke patients need to be indicated for intravenous tissue plasminogen activator and mechanical thrombectomy as hyperacute therapy. We describe the latest evidence and therapeutic indications for mechanical thrombectomy.